Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.67B | 1.03B | -1.07B | 1.50B | 634.43M | Gross Profit |
1.67B | 1.03B | -1.07B | 1.50B | 634.43M | EBIT |
380.80M | 1.70M | -142.57M | 31.16M | 55.09M | EBITDA |
49.70M | 16.40M | -48.40M | 42.19M | 52.04M | Net Income Common Stockholders |
3.90M | 18.70M | -98.33M | 27.29M | 21.19M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
138.00M | 146.00M | 175.29M | 70.09M | 105.35M | Total Assets |
12.76B | 12.13B | 11.14B | 9.42B | 8.86B | Total Debt |
206.20M | 209.30M | 213.23M | 49.46M | 71.44M | Net Debt |
68.20M | 63.30M | 37.93M | -20.63M | -33.62M | Total Liabilities |
12.44B | 11.77B | 10.81B | 8.96B | 8.37B | Stockholders Equity |
314.40M | 359.90M | 333.12M | 458.17M | 487.07M |
Cash Flow | Free Cash Flow | |||
37.80M | -35.70M | -80.43M | 20.69M | 49.34M | Operating Cash Flow |
38.60M | -34.90M | -76.92M | 24.32M | 50.20M | Investing Cash Flow |
5.00M | 29.50M | 52.05M | -3.64M | 1.88M | Financing Cash Flow |
-49.70M | -49.80M | 127.03M | -49.98M | -59.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | £22.43B | 13.16 | 12.68% | 2.02% | -17.12% | 30.62% | |
67 Neutral | £431.26M | 110.66 | 1.16% | 8.65% | 22.19% | -79.23% | |
65 Neutral | £6.20B | ― | -60.34% | 8.69% | -6.33% | ― | |
64 Neutral | $12.78B | 9.87 | 7.67% | 17015.06% | 12.34% | -5.99% | |
60 Neutral | $550.81M | 4.53 | -6.71% | ― | 3.73% | -172.06% | |
57 Neutral | £203.27M | ― | -127.10% | ― | -20.62% | -44.64% | |
56 Neutral | £64.11M | 40.09 | 8.08% | 9.47% | 35.39% | -76.12% |
Chesnara PLC announced the appointment of Carol Hagh as the new Senior Independent Director, succeeding Jane Dale who retired after a nine-year tenure. This leadership change is expected to leverage Carol’s experience to continue enhancing the company’s governance and strategic direction, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara PLC announced that all resolutions proposed at its 2025 Annual General Meeting were passed with a significant majority. This includes the adoption of audited accounts, approval of the Directors’ Remuneration Report, declaration of a final dividend, and the re-appointment of several directors and auditors. The successful passing of these resolutions reflects strong shareholder support and positions Chesnara to continue its strategic initiatives and maintain its market position.
The most recent analyst rating on (GB:CSN) stock is a Buy with a £320.00 price target. To see the full list of analyst forecasts on Chesnara stock, see the GB:CSN Stock Forecast page.
Chesnara plc announced that Emma Dawe, the newly appointed Group General Counsel, has been granted an award over the company’s ordinary shares under the 2023 Long Term Incentive Plan. This move aligns with the Directors’ Remuneration Policy approved by shareholders and reflects Chesnara’s commitment to strategic leadership. The award, subject to performance targets over three years, underscores the company’s focus on long-term growth and stability, potentially impacting its market positioning positively.
Chesnara PLC has announced its 2025 Annual General Meeting, scheduled for May 13, 2025, at Panmure Liberum’s offices in London. The company encourages electronic voting and pre-submission of questions by shareholders. The preliminary results for 2024 were released on March 27, 2025, proposing a final dividend of 16.08 pence per share. This announcement underscores Chesnara’s commitment to transparency and shareholder engagement, reflecting its ongoing strategic focus on delivering value and maintaining strong financial performance.
Chesnara has applied for a Block Listing of 1.5 million ordinary shares on the London Stock Exchange, with the shares to be issued under staff incentive schemes. This move is expected to meet the company’s requirements for the next two years and reflects its ongoing commitment to incentivizing staff while maintaining shareholder value.
Chesnara PLC announced a share transaction involving its Group Chief Risk Officer and Chief Actuary, Gavin Hughes, who transferred 3,275 ordinary shares to his wife, Emma Hughes. This transaction, conducted off-market, is aligned with regulatory requirements and reflects internal shareholding adjustments within the company.
Chesnara has applied for a block listing of 1.5 million ordinary shares on the London Stock Exchange to support its staff incentive schemes over the next two years. This move aligns with its strategic focus on efficient policy administration and value addition through new business and acquisitions, reinforcing its market position and commitment to stakeholders.
Chesnara PLC announced its total voting rights, with an issued share capital of 150,997,019 ordinary shares, each carrying one voting right. This information is crucial for shareholders to determine their interest in the company under the FCA’s rules, reflecting Chesnara’s commitment to transparency and regulatory compliance.
Chesnara plc has announced the granting of awards to its key executives under the 2023 Short Term Incentive Scheme and the Long Term Incentive Plan. These awards, which involve ordinary shares of the company, are part of the Directors’ Remuneration Policy approved by shareholders. The grants are designed to align the interests of the executives with those of the shareholders, potentially impacting the company’s operational focus and stakeholder value.
Chesnara plc announced that its Executive Directors, Steven Murray and Thomas Howard, have purchased ordinary shares in the company, with transactions conducted on the London Stock Exchange. This move is part of the company’s ongoing efforts to align management interests with those of shareholders, potentially signaling confidence in Chesnara’s strategic direction and financial health.
Chesnara plc reported strong financial results for 2024, with a 14% increase in cash generation to £60m and a robust solvency coverage ratio of 203%. The company continues its 20-year streak of dividend growth, proposing a 3% increase in the final dividend. The acquisition of a Canada Life portfolio contributed to a £69m growth in Economic Value earnings, enhancing Chesnara’s strategic position and providing flexibility for future M&A activities.
Chesnara PLC announced it will report its financial results for the year ended December 31, 2024, on March 27, 2025. A presentation for analysts and investors will be held in London and available online. This announcement reflects Chesnara’s ongoing commitment to transparency and stakeholder engagement, potentially impacting investor confidence and market positioning.
Chesnara PLC announced it will report its financial results for the year ended December 31, 2024, on March 27, 2025. The company will host a presentation for analysts and investors, which will be available online and posted on its corporate website. This announcement reflects Chesnara’s ongoing commitment to transparency and stakeholder engagement, potentially impacting its market positioning and investor relations.